dianeal for peritoneal dialysis anhydrouse dextrose sodium chloride lactate calcium magnesium injection solution
baxter healthcare corporation - anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok) - anhydrous dextrose 13.6 g in 1000 ml
stoptussin
teva czech industries s.r.o. - butamirate (butamirate citrate), guaifenesin - tablets - 4mg+100mg
stoptussin
teva operations poland sp. z o.o - guaifenesin, butamirate (butamirate citrate) - tablets - 100mg+4mg
compound magnesium trisilicate tablets magnesium trisilicate 250 mg, dried aluminium hydroxide gel 120 mg
medopharm, india - magnesium trisilicate bp , dried aluminium hydroxide gel bp - tablets - magnesium trisilicate 250 mg, dried aluminium hydroxide gel 120 mg
magnesium hydroxide oral suspension
a a h pharmaceuticals ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml
magnesium hydroxide oral suspension
the boots company plc - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml
magnesium hydroxide oral suspension
j m loveridge ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml
magnesium hydroxide oral suspension
thornton & ross ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml
magnesium hydroxide oral suspension
alliance healthcare (distribution) ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml
sulfasalazine- sulfasalazine tablet
preferred pharmaceuticals, inc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets are indicated: sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides or salicylates. none reported.